Browse > Article
http://dx.doi.org/10.5012/bkcs.2013.34.3.899

Docking, CoMFA and CoMSIA Studies of a Series of N-Benzoylated Phenoxazines and Phenothiazines Derivatives as Antiproliferative Agents  

Ghasemi, Jahan B. (Chemistry Department, Faculty of Sciences, K. N. Toosi University of Technology)
Aghaee, Elham (Chemistry Department, Faculty of Sciences, K. N. Toosi University of Technology)
Jabbari, Ali (Chemistry Department, Faculty of Sciences, K. N. Toosi University of Technology)
Publication Information
Abstract
Using generated conformations from docking analysis by Gold algorithm, some 3D-QSAR models; CoMFA and CoMSIA have been created on 39 N-benzoylated phenoxazines and phenothiazines, including their S-oxidized analogues. These molecules inhibit the polymerization of tubulin into microtubules and thus they have been studied for the development of antitumor drugs. Training set for the CoMFA and CoMSIA models using 30 docked conformations gives $q^2$ Leave one out (LOO) values of 0.756 and 0.617, and $r^2$ ncv values of 0.988 and 0.956, respectively. The ability of prediction and robustness of the models were evaluated by test set, cross validation (leave-one-out and leave-ten-out), bootstrapping, and progressive scrambling approaches. The all-orientation search (AOS) was used to achieve the best orientation to minimize the effect of initial orientation of the structures. The docking results confirmed CoMFA and CoMSIA contour maps. The docking and 3D-QSAR studies were thoroughly interpreted and discussed and confirmed the experimental $pIC_{50}$ values.
Keywords
Phenoxazines and phenothiazines derivatives; Tubulin; CoMFA; CoMSIA; Docking;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Checchi, P. M.; Nettles, J. H.; Zhou, J.; Snyder, J. P.; Joshi, H. C. Trends Pharmacol. Sci. 2003, 24, 361.   DOI   ScienceOn
2 Nogales, E. Annu. Rev. Biochem. 2000, 69, 277.   DOI   ScienceOn
3 Jordan, M. A.; Wilson, L. Nat. Rev. Cancer 2004, 4, 253.   DOI   ScienceOn
4 Valiron, O.; Caudron, N.; Job, D. Cell Mol. Life Sci. 2001, 58, 2069.   DOI
5 Jordan, A.; Hadfield, J. A.; Lawrence, N. J.; McGown, A. T. Med. Res. Rev. 1998, 18, 259.   DOI   ScienceOn
6 Seibel, N. L.; Reaman, G. H. Invest. New Drugs 1996, 14, 49.   DOI
7 Schiff, P. B.; Horwitz, S. B. Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 1561.   DOI   ScienceOn
8 Pellegrini, F.; Budman, D. R. Cancer Invest. 2005, 23, 264.   DOI   ScienceOn
9 Hearn, B. R.; Shaw, S. J.; Myles, D. C. Compr. Med. Chem. II 2007, 7, 81.
10 Li, Q.; Sham, H. L. Expert Opin. Ther. Patents 2002, 12, 1663.   DOI
11 Hadfield, J. A.; Ducki, S.; Hirst, N.; McGown, A. T. Prog. Cell Cycle Res. 2003, 5, 309.
12 Ghasemi, J. B.; Meftahi, N. J. Enzyme Inhib. Med. Chem. 2013, 28, 320.   DOI   ScienceOn
13 Lill, M. A. Drug Discov. Today 2007, 12, 1013.   DOI   ScienceOn
14 Yang, G. F.; Huang, X. Curr. Pharm. Des. 2006, 12, 4601.   DOI
15 Pirhadi, S.; Ghasemi, J. B. Eur. J. Med. Chem. 2010, 45, 4897.   DOI   ScienceOn
16 Gayathri, P.; Pande, V.; Sivakumar, R.; Gupta, S. P. Bioorg. Med. Chem. 2001, 9, 3059.   DOI   ScienceOn
17 Cramer, R. D.; Patterson, D. E.; Bunce, J. D. J. Am. Chem. Soc. 1988, 110, 5959.   DOI   ScienceOn
18 Klebe, G.; Abraham, U.; Mietzner, T. J. Med. Chem. 1994, 37, 4130.   DOI   ScienceOn
19 Ghasemi, J. B.; Pirhadi, S.; Ayati, M. Bull. Korean Chem. Soc. 2011, 32, 645.   DOI   ScienceOn
20 Sirois, S.; Wei, D. Q.; Du, Q. S.; Chou, K. C. J. Chem. Inf. Comput. Sci. 2004, 44. 1111.   DOI   ScienceOn
21 Zhao, T. T.; Lu, X.; Yang, X. H.; Wang, L. M.; Li, X.; Wang, Z. C.; Gong, H. B.; Zhu, H. L. Bioorg. Med. Chem. 2012, 20, 3233.   DOI   ScienceOn
22 Liao, Q. H.; Gao, Q. Z.; Wei, J.; Chou, K. C. Med. Chem. 2011, 7,24.   DOI   ScienceOn
23 Liu, X. Y.; Wang, R. L.; Xu, W. R.; Tang, L. D.; Wang, S. Q.; Chou, K. C. Protein. Peptide. Lett. 2011, 18, 1021.   DOI
24 Chou, K. C. Curr. Med. Chem. 2004, 11, 2105.   DOI   ScienceOn
25 Liao, S. Y.; Chen, J. C.; Miao, T. F.; Shen, Y.; Zheng, K. C. J. Enzyme Inhib. Med. Chem. 2010, 25, 421.   DOI   ScienceOn
26 Liao, S. Y.; Qian, L.; Miao, T. F.; Lu, H. L.; Zheng, K. C. Eur. J. Med. Chem. 2009, 44, 2822.   DOI   ScienceOn
27 Prinz, H.; Chamasmani, B.; Vogel, K.; Bohm, K. J.; Aicher, B.; Gerlach, M.; Gunther, E. G.; Amon, P.; Ivanov, I.; Muller, K. J. Med. Chem. 2011, 54, 4247.   DOI   ScienceOn
28 Momany, F. A.; Rone, R. J. J. Comput. Chem. 1992, 13, 888.   DOI
29 Discovery Studio. Accelrys Software Inc, San Diego, CA, 2009.
30 Politi, A.; Durdagi, S.; Moutevelis-Minakakis, P.; Kokotos, G.; Mavromoustakos, T. J. Mol. Graph. Model 2010, 29, 425.   DOI   ScienceOn
31 http://www.ccdc.cam.ac.uk/support/documentation/gold/3_1/gold31. pdf.
32 Tripos, QSARTM Manual, SYBYL, version 7.3, 2006, St. Louis, 2006.
33 Baroni, M.; Costantino, G.; Cruciani, G.; Riganelli, D.; Valigi, R.; Clementi, S. Quant. Struct.-Act. Relat. 1993, 12, 9.   DOI   ScienceOn
34 Cho, S. J.; Tropsha, A. J. Med. Chem. 1995, 38, 1060.   DOI   ScienceOn
35 Wang, R.; Gao, Y.; Liu, L.; Lai, L. J. Mol. Model 1998, 4, 276.   DOI
36 Clark, R.; Fox, P. J. Comput. Aided Mol. Des. 2004, 18, 563.   DOI   ScienceOn
37 Cramer, R. D.; Patterson, D. E.; Bunce, J. D. J. Am. Chem. Soc. 1988, 110, 5959.   DOI   ScienceOn